Dr. Reddy's Laboratories Ltd. closed 13.36% short of its 52-week high of 1,420.20 rupees, which the company reached on August ...

Dr. Reddy's Laboratories Ltd. closed 13.05% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Shares of Dr Reddys Laboratories experienced a decline of 0.67% to Rs 1228.00 during today's trading session, accompanied by ...

Dr Reddys Laboratories shares experienced notable trading activity, with the price currently at Rs 1215.40, reflecting a 0.69 ...

Stay updated with the Dr Reddys Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

Discover why Dr. Reddy’s Laboratories remains a strong buy amid robust revenue growth, underappreciated pipeline potential, ...

Dr Reddy's Laboratories Ltd (NYSE:RDY) achieved record high revenue exceeding $3.8 billion and crossed the $1 billion threshold in EBITDA for the first time. The company reported a year-over-year ...

The sharp 250 basis points quarter-on-quarter decline in gross margin (the third consecutive sequential fall) reinforces ...

Hyderabad: Dr Reddy's Laboratories Limited has informed in a BSE filing that Dr Reddy's Laboratories SA, Switzerland, a ...

Dr. Reddy's Laboratories added 3.34% to Rs 1,193.75 after the company reported a consolidated net profit of Rs 1,594 crore for the quarter ended March 2025 (Q4FY25), marking a 22% year-on-year ...

Hyderabad: Dr Reddy's Labs has announced the re-appointment of G V Prasad as Co-Chairman and Managing Director for a period ...

Alkem Laboratories, Sun Pharma, Dr Reddy's Labs, and Angel One face data breaches, highlighting the need for cyber security ...